# Use of GM-CSF Treatment in Recurrent Implantation Failure

> **NCT01715974** · PHASE3 · UNKNOWN · sponsor: **Centre for Endocrinology and Reproductive Medicine, Italy** · enrollment: 140 (estimated)

## Conditions studied

- Women With Recurrent Implantation Failure in IVF

## Interventions

- **DRUG:** GM-CSF group
- **DRUG:** CONTROL

## Key facts

- **NCT ID:** NCT01715974
- **Lead sponsor:** Centre for Endocrinology and Reproductive Medicine, Italy
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-12
- **Primary completion:** 2022-07-31
- **Final completion:** 2022-08
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2022-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01715974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01715974, "Use of GM-CSF Treatment in Recurrent Implantation Failure". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01715974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*